Biohaven Ltd Share Price Today: Live Updates & Key Insights
Biohaven Ltd share price today is $14.12, up -2.25%. The stock opened at $14.68 against the previous close of $14.65, with an intraday high of $14.68 and low of $13.88.
Biohaven Ltd Share Price Chart
Biohaven Ltd
Biohaven Ltd Share Price Performance
Biohaven Ltd Institutional Holdings
Biohaven Ltd Market Status
Biohaven Ltd Fundamentals
Market Cap 2205.72 M
PB Ratio 17.1488
PE Ratio 0.0
Enterprise Value 2159.13 M
Total Assets 451.45 M
Volume 1718104
Biohaven Ltd Company Financials
About Biohaven Ltd & investment objective
Company Information Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA nephropathy; BHV-1600, which is in Phase 1 clinical trial for the treatment of peripartum cardiomyopathy; BHV-8000 that is in Phase 3 clinical trial for treating Parkinson's disease; Opakalim, which is in Phase 3 clinical trial for the treatment of focal epilepsy; BHV-2100 that is in Phase 2 clinical trial for the treatment of pain disorders; and BHV-2000, which is in Phase 2 clinical trial for treating obesity. The company is also developing BHV-1510 that is in Phase 2 clinical trial for the treatment of advanced or metastatic epithelial tumors; and BHV-1530, which is in Phase 2 clinical trial for treating urothelial cancer and other tumors. In addition, its preclinical product pipeline includes BHV-1310 for treating myasthenia gravis; BHV-1320 for treating immune mediated-diseases; BHV-1450 for treating Pemphigus, MuSK MG, and LGI-1 Encephalitis; BHV-1420 for treating membranous nephropathy; BHV-1440 for treating Graves' disease and TED; BHV-6500 for treating type 1 diabetes; BHV-1490 for treating IgM neuropathy and Waldenstrom's; BHV-8100 for treating neurodegenerative diseases; and BHV-1955 for treating tinnitus. The company was formerly known as Biohaven Research Ltd. and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.
Organisation Biotechnology
Employees 274
Industry Biotechnology
CEO Dr. Vladimir Coric M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Biohaven Ltd FAQs
What is the share price of Biohaven Ltd today?
The current share price of Biohaven Ltd is $14.12.
Can I buy Biohaven Ltd shares in India?
Yes, Indian investors can buy Biohaven Ltd shares by opening an international trading and demat account with Motilal Oswal.
How to buy Biohaven Ltd shares in India?
You can easily invest in Biohaven Ltd shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Biohaven Ltd shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Biohaven Ltd.
Can I buy fractional shares of Biohaven Ltd?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Biohaven Ltd?
Biohaven Ltd has a market cap of $2205.72 M.
In which sector does Biohaven Ltd belong?
Biohaven Ltd operates in the Biotechnology sector.
What documents are required to invest in Biohaven Ltd stocks?
To invest, you typically need:
What is the PE and PB ratio of Biohaven Ltd?
The PE ratio of Biohaven Ltd is N/A and the PB ratio is 17.15.